Covalent fragment-based drug discovery for target tractability

Area of Science:

• Medicinal Chemistry
• Chemical Biology
• Drug Discovery

Background:

• Prioritizing tractable protein targets is crucial for drug discovery.
• Targets must bind small molecules and alter disease biology.
• Covalent fragment-based drug discovery (CFBDD) is a powerful strategy.

Purpose of the Study:

• To provide an overview of recent CFBDD approaches.
• To discuss the application of CFBDD in target identification.
• To highlight the tractability of unexplored binding sites on protein targets.

Main Methods:

• Overview of recent covalent fragment-based screening techniques.
• Application of these techniques in drug discovery.
• Analysis of proteome-wide screening in cellular contexts.

Main Results:

• CFBDD enables identification of fragment hits for difficult protein targets.
• Allows for cellular context screening and functional effect determination.
• Demonstrates tractability of previously unexplored binding sites.

Conclusions:

• Covalent fragment-based drug discovery is effective for identifying tractable protein targets.
• This method facilitates the exploration of challenging binding sites.
• It aids in developing novel therapeutics for various diseases.